Vivani Medical Inc（VANI）财务数据VANIVivani Medical Inc

Evaluating the bottom line, Vivani Medical Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -220.40%, provide a clear picture of how effectively VANI converts its operational activities into shareholder value.

In the context of the broader market, VANI competes directly with industry leaders such as APYX and QTRX. With a market capitalization of $126.28M, it holds a significant position in the sector. When comparing efficiency, VANI's gross margin of N/A stands against APYX's 63.89% and QTRX's 38.52%. Such benchmarking helps identify whether Vivani Medical Inc is trading at a premium or discount relative to its financial performance.

Vivani Medical has been experiencing negative net income, with losses around -6.3 million USD in recent quarters. The current ratio is strong at 3.25, indicating good short-term financial health, but the company has a high price-to-book ratio of 6.75, suggesting it may be overvalued relative to its equity.